Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 782581, 12 pages
http://dx.doi.org/10.1155/2013/782581
Research Article

Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma

1Department of Hepatobiliary Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, China
2Department of Hepatobiliary Surgery, Drum Tower Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu 210008, China
3School of Medicine, Nanjing University, Nanjing, Jiangsu 210093, China

Received 30 July 2013; Accepted 27 August 2013

Academic Editor: Qiang Xia

Copyright © 2013 Guang Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [21 citations]

The following is the list of published articles that have cited the current article.

  • Monica Cojoc, Katrin Mäbert, Michael H. Muders, and Anna Dubrovska, “A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms,” Seminars in Cancer Biology, 2014. View at Publisher · View at Google Scholar
  • Zhiwei Sun, Xicheng Wang, Jing Gao, Yanyan Li, Xiaodong Zhang, and Lin Shen, “Correlation of ABCG2 expression with the efficacy of irinotecan chemotherapy in colorectal cancer patients,” Chinese Journal of Clinical Oncology, vol. 41, no. 7, pp. 430–433, 2014. View at Publisher · View at Google Scholar
  • Jun-Kyum Kim, Hee-Young Jeon, and Hyunggee Kim, “The molecular mechanisms underlying the therapeutic resistance of cancer stem cells,” Archives of Pharmacal Research, 2014. View at Publisher · View at Google Scholar
  • Zhongxia Wang, Chunping Jiang, Weibo Chen, Guang Zhang, Dongjun Luo, Yin Cao, Junhua Wu, Yitao Ding, and Baorui Liu, “Baicalein Induces Apoptosis and Autophagy via Endoplasmic Reticulum Stress in Hepatocellular Carcinoma Cells,” BioMed Research International, vol. 2014, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Anna Bergamaschi, Zeynep Madak-Erdogan, Yu Jin Kim, Yoon-La Choi, Hailing Lu, and Benita S. Katzenellenbogen, “The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of ste,” Breast Cancer Research, vol. 16, no. 5, 2014. View at Publisher · View at Google Scholar
  • Ming Sun, Chuanxu Yang, Jin Zheng, Miao Wang, Muwan Chen, Dang Quang Svend Le, Jørgen Kjems, and Cody Eric Bünger, “Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense,” Acta Biomaterialia, 2015. View at Publisher · View at Google Scholar
  • Sheng-xian Yuan, Jie Wang, Fu Yang, Qi-fei Tao, Jin Zhang, Li-li Wang, Yuan Yang, Hui Liu, Zhen-guang Wang, Qing-guo Xu, Jia Fan, Lei Liu, Shu-han Sun, and Wei-ping Zhou, “ Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1 ,” Hepatology, 2015. View at Publisher · View at Google Scholar
  • Guo Zhe, Xiang Bangde, Jiang Jinghang, Zhang Jun, Zhong Yanping, Su Jie, and Li Lequn, “Isolation and stem cell property assessment of side population cells in hepatocel-lular carcinoma cell lines,” Chinese Journal of Cancer Biotherapy, vol. 22, no. 2, pp. 220–224, 2015. View at Publisher · View at Google Scholar
  • Young Lee, Seung Ryu, Se Bae, Tae Park, Kang Kwon, Yun Noh, and Sung Kim, “Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer,” Oncology Reports, 2015. View at Publisher · View at Google Scholar
  • Yuan Yuan, Zhulin Yang, Xiongying Miao, Daiqiang Li, Ziru Liu, and Qiong Zou, “The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma,” Tumor Biology, vol. 36, no. 12, pp. 9961–9968, 2015. View at Publisher · View at Google Scholar
  • Xiao-Ge Zhao, Mei-Li Tian, Yang Yang, Dong-Dong Tong, and Wei Chen, “The increase of tumor stem cells in the presence of cisplatin on human hepatocellular carcinoma HepG2 cell line,” Journal of Xi'an Jiaotong University (Medical Sciences), vol. 36, no. 1, pp. 89–92, 2015. View at Publisher · View at Google Scholar
  • Ilaria Dando, Marco Cordani, Elisa Dalla Pozza, Giulia Biondani, Massimo Donadelli, and Marta Palmieri, “Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Chaonan Chu, Ting Yang, Jingting Cai, Tianfang Peng, Jing Wang, Jingli Zhang, Hui Hu, Dihong Tang, and Huining Liu, “Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3,” Cellular Physiology and Biochemistry, vol. 39, no. 4, pp. 1421–1432, 2016. View at Publisher · View at Google Scholar
  • Shaojie Jiang, Xuhui Li, Shuang Lin, Senjun Zhou, Xiaolong Liu, Yifan Wang, Xueyong Zheng, Haimeng Zhou, and Xiujun Cai, “NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma,” Oncology Reports, vol. 36, no. 2, pp. 853–862, 2016. View at Publisher · View at Google Scholar
  • Wen-Jing Wang, Hannah Chang, Hua Sui, Cong Qi, Qi Li, Jie Zhang, Ying-Yu Lu, Piao-Ting Guo, Shao-Fei Wu, Ming-Zhu Mei, and Yi-Ting Wan, “Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro,” Oncology Reports, vol. 36, no. 1, pp. 428–440, 2016. View at Publisher · View at Google Scholar
  • Zhe Guo, Jing-Hang Jiang, Jun Zhang, Hao-Jie Yang, Yan-Ping Zhong, Jie Su, Ri-Rong Yang, Le-Qun Li, and Bang-De Xiang, “Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells,” Oncology Letters, vol. 11, no. 5, pp. 3145–3151, 2016. View at Publisher · View at Google Scholar
  • Shigeo Nohara, Kazunori Kato, Daisuke Fujiwara, Naoya Sakuragi, Kazuyoshi Yanagihara, Yoshimi Iwanuma, and Yoshiaki Kajiyama, “Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer,” Clinics and Research in Hepatology and Gastroenterology, 2016. View at Publisher · View at Google Scholar
  • Zorica Milošević, Jasna Banković, Ana Podolski-Renić, Jelena Dinić, Tijana Stanković, and Milica Pešić, “Mutual regulation and targeting of multidrug resistance and cancer stem phenotype,” MedChemComm, vol. 7, no. 12, pp. 2265–2281, 2016. View at Publisher · View at Google Scholar
  • Hussam S. Eltoukhy, Garima Sinha, Caitlyn Moore, Oleta A. Sandiford, and Pranela Rameshwar, “Immune Modulation by a Cellular Network of Mesenchymal Stem Cells and Breast Cancer Cell Subsets: Implication for Cancer Therapy,” Cellular Immunology, 2017. View at Publisher · View at Google Scholar
  • Jiaying Lin, and Ding Ding, “The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis,” Cancer Cell International, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Yanhong Xiao, Mei Lin, Xingmao Jiang, Jun Ye, Ting Guo, Yujuan Shi, and Xuefeng Bian, “The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy,” Analytical Cellular Pathology, vol. 2017, pp. 1–9, 2017. View at Publisher · View at Google Scholar